Advanced search
Publication Cover
Journal of Medical Economics Volume 22, 2019 - Issue 11
Submit an article Journal homepage
1,817
Views
9
CrossRef citations to date
0
Altmetric
Oncology

Economic modeling to evaluate the impact of chronic myeloid leukemia therapy management on the oncology care model in the US

Elias J. JabbourThe University of Texas MD Anderson Cancer Center, Houston, TX, USA; Correspondence[email protected]
,
Martin F. MendiolaBristol-Myers Squibb, Princeton, NJ, USA;
,
Melissa Lingohr-SmithNovosys Health, Green Brook, NJ, USA
,
Jay LinNovosys Health, Green Brook, NJ, USA
&
Dinara MakenbaevaBristol-Myers Squibb, Princeton, NJ, USA;
Pages 1113-1118 | Received 04 Mar 2019, Accepted 09 May 2019, Published online: 31 May 2019

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Marwa S Hamza, Samia A Shouman, Raafat Abdelfattah, Heba S Moussa & Mervat M Omran. (2022) Determination of the Cut-off Value for Imatinib Plasma Levels Linked to Occurrence of Bone Pain in CML Patients. Drug Design, Development and Therapy 16, pages 1595-1604.
Read now

Articles from other publishers (8)

Rumjhum Agrawal, Joao Vieira, Jacqueline Ryan, Harish Negi, Tanvi Rajput, Regina Corbin & Ricardo Viana. (2022) A Systematic Literature Review of the Economic Evaluations of Treatments for Patients with Chronic Myeloid Leukemia. PharmacoEconomics 40:12, pages 1159-1186.
Crossref
Abdülkadir Erçalışkan, Duygu Seyhan Erdoğan & Ahmet Emre Eşkazan. (2021) Current evidence on the efficacy and safety of generic imatinib in CML and the impact of generics on health care costs. Blood Advances 5:17, pages 3344-3353.
Crossref
Joel E. Segel, Eric W. Schaefer, Nicholas G. Zaorsky, Christopher S. Hollenbeak, Haleh Ramian & Jay D. Raman. (2021) Potential Winners and Losers: Understanding How the Oncology Care Model May Differentially Affect Hospitals. JCO Oncology Practice 17:8, pages e1150-e1161.
Crossref
Dmitry A. Andreev, Aleksander A. Zavyalov & Tatiana N. Ermolaeva. (2021) Methodological outlines for assessing the costs of cancer patients care. HEALTH CARE OF THE RUSSIAN FEDERATION 65:2, pages 125-134.
Crossref
Jennifer J. Wilkes, Gary H. Lyman, David R. Doody, Shasank Chennupati, Laura K. Becker, Pamela E. Morin, Lena E. Winestone, Henry J. Henk & Eric J. Chow. (2021) Health Care Cost Associated With Contemporary Chronic Myelogenous Leukemia Therapy Compared With That of Other Hematologic Malignancies. JCO Oncology Practice 17:3, pages e406-e415.
Crossref
Benyam Muluneh, Rena M. Conti, Joehl Nguyen, Ashley Cole, Richard A. Larson & Stacie B. Dusetzina. 2021. Chronic Myeloid Leukemia. Chronic Myeloid Leukemia 93 104 .
Sudeep Banerjee, Abhishek Kumar, Nicole Lopez, Beiqun Zhao, Chih-Min Tang, Mayra Yebra, Hyunho Yoon, James D. Murphy & Jason K. Sicklick. (2020) Cost-effectiveness Analysis of Genetic Testing and Tailored First-Line Therapy for Patients With Metastatic Gastrointestinal Stromal Tumors. JAMA Network Open 3:9, pages e2013565.
Crossref
Domenico Russo, José Valentín Garcia-Gutierrez, Simona Soverini & Michele Baccarani. (2020) Chronic Myeloid Leukemia Prognosis and Therapy: Criticisms and Perspectives. Journal of Clinical Medicine 9:6, pages 1709.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.